Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
Jensen LO, Vikman S, Antonsen L, Kosonen P, Niemelä M, Christiansen EH, Kervinen K, Erglis A, Harnek J, Kumsars I, Thuesen L, Niemelä K. Jensen LO, et al. Among authors: harnek j. Cardiovasc Revasc Med. 2017 Dec;18(8):577-582. doi: 10.1016/j.carrev.2017.05.010. Epub 2017 May 12. Cardiovasc Revasc Med. 2017. PMID: 29066343
Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS).
Kosonen P, Vikman S, Jensen LO, Lassen JF, Harnek J, Olivecrona GK, Erglis A, Fossum E, Niemelä M, Kervinen K, Ylitalo A, Pietilä M, Aaroe J, Kellerth T, Saunamäki K, Thayssen P, Hellsten L, Thuesen L, Niemelä K. Kosonen P, et al. Among authors: harnek j. Int J Cardiol. 2013 Sep 30;168(2):1010-6. doi: 10.1016/j.ijcard.2012.10.033. Epub 2012 Nov 17. Int J Cardiol. 2013. PMID: 23164593 Clinical Trial.
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Erlinge D, et al. Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X. Lancet. 2021. PMID: 33714389
Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
Råmunddal T, Hoebers LP, Henriques JP, Dworeck C, Angerås O, Odenstedt J, Ioanes D, Olivecrona G, Harnek J, Jensen U, Aasa M, Albertsson P, Wedel H, Omerovic E. Råmunddal T, et al. Among authors: harnek j. JACC Cardiovasc Interv. 2016 Aug 8;9(15):1535-44. doi: 10.1016/j.jcin.2016.04.031. JACC Cardiovasc Interv. 2016. PMID: 27491603 Free article.
Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.
Kedhi E, Gomes ME, Lagerqvist B, Smith JG, Omerovic E, James S, Harnek J, Olivecrona GK. Kedhi E, et al. Among authors: harnek j. JACC Cardiovasc Interv. 2012 Nov;5(11):1141-9. doi: 10.1016/j.jcin.2012.06.020. JACC Cardiovasc Interv. 2012. PMID: 23174638 Free article.
Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation).
Harnek J, Webb JG, Kuck KH, Tschope C, Vahanian A, Buller CE, James SK, Tiefenbacher CP, Stone GW. Harnek J, et al. JACC Cardiovasc Interv. 2011 Jan;4(1):115-22. doi: 10.1016/j.jcin.2010.08.027. JACC Cardiovasc Interv. 2011. PMID: 21251638 Free article. Clinical Trial.
62 results